---
schema_version: "secwatch.filing_event.v1"
accession: "0001477449-26-000046"
form_type: "8-K"
ticker: "TDOC"
cik: "0001477449"
company_name: "Teladoc Health, Inc."
filed_at: "2026-09-25T12:30:07+00:00"
generated_at: "2026-10-12T13:19:17.911156+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Teladoc Chief Legal Officer Adam Vandervoort resigns effective Nov 1, 2026; Jonathan Dorfman named successor

## Summary
- Adam C. Vandervoort, Chief Legal Officer and Secretary, informed Teladoc on September 24, 2026 he will resign effective November 1, 2026.
- Resignation was made 'with good reason' under his executive severance agreement, implying a constructive-termination claim.
- Jonathan Dorfman, currently SVP, Securities & Corporate Law, will assume the Chief Legal Officer and Secretary role.
- Vandervoort will provide transition advisory services until November 1, 2027 and will receive no compensation for them.
- Filing signed by Vandervoort as Chief Legal Officer on September 25, 2026; no other officer or director changes disclosed.

## SEC filing metadata
- accession: 0001477449-26-000046
- form_type: 8-K
- ticker: TDOC
- cik: 0001477449
- company_name: Teladoc Health, Inc.
- filed_at: 2026-09-25T12:30:07+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1477449/000147744926000046/0001477449-26-000046-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1477449/000147744926000046/tdoc-20260924.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477449-26-000046
- JSON: https://secwatch.observer/filing/0001477449-26-000046.json
- Plain text: https://secwatch.observer/filing/0001477449-26-000046.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.